Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Accord Healthcare
Accord Healthcare
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Carthera signs strategic collaboration with Accord Healthcare
Partnership will further development, manufacturing and commercialisation of carboplatin to be used with SonoCloud system for the treatment of recurrent glioblastoma
Analysis
Accord Healthcare implements next generation of Ci-DMS
The project has already reaped many benefits including greater accuracy and efficiency when dispensing material weights
Media
Accord Healthcare opens new UK factory to increase EU presence
New site to be EMENA centre for excellence and create more than 500 jobs
Pharmaceutical
Intas first Indian company to launch biosimilar in EU, US and Japan
The company has launched its first biosimilar, filgrastim, in Europe, through its wholly owned subsidiary Accord Healthcare
Subscribe now